Top Markets
Coin of the day
ContextVision AB (publ) ContextVision AB (publ)

ContextVision AB (publ)

0L8Z
株式のランク #27947
ContextVision AB (publ), a Swedish medical technology company established in... ContextVision AB (publ), a Swedish medical technology company established in 1983 and headquartered in Stockholm, develops sophisticated image analysis and artificial intelligence software. These solutions are supplied to original equipment manufacturers (OEMs) across Asia, Europe, and the United States. The firm specializes in enhancing image quality for various medical imaging technologies, including 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and mammography. Key products in their lineup include Rivent, which delivers exceptional image clarity for diverse ultrasound applications such as women's health, general imaging, cardiovascular, and point-of-care. They also offer VolarView for improved visuals in handheld ultrasound devices, and GOPiCE, providing real-time volumetric image enhancement. Furthermore, ContextVision provides Altumira/Altumira Plus, a dedicated platform for digital radiography, alongside an Orthopedic Package for skeletal imaging. Their offerings extend to GOPView MRI2Plus for advanced MRI image refinement and INIFY Prostate Screening, a tool for the digital analysis of prostate biopsies.
株価
$0.39098275
最終同期: 2026-02-11
時価総額
$29.58M
変化(1日)
0.01%
変化(1年)
-12.48%
SE
取引 ContextVision AB (publ) (0L8Z)

カテゴリー

ContextVision AB (publ)(0L8Z)の営業利益率
2026 時点の営業利益率 TTM: 0.00%
ContextVision AB (publ) の最新の財務報告と株価によると、現在の営業利益率(TTM)は 0.00% です。2026 年末時点では 0.00% でした。
ContextVision AB (publ) の営業利益率の履歴(2026 から 2026)
各年末の営業利益率
営業利益率 変化
提供された日付のデータは十分ではありません。
同業他社の営業利益率
企業 営業利益率 営業利益率の差
25.80% -
DE
0.00% -
CA
21.94% -
US
12.47% -
US
11.40% -
US
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。